
While hospital chains are expanding capacity at a healthy rate, key growth drivers of pharma companies are showing signs of moderation

Business enterprises are increasingly looking to save costs deploying artificial intelligence and automation tools

The company achieved EBITDA breakeven in AHL, its pharma business, one quarter earlier than estimated

Subsidy rates for the 2024 Kharif cropping season will be the key factor to watch

Revenue performance in-line, but tad weaker margin and guidance

Good quarter on the back of strong loan growth and better asset quality

The new CEO will have to address the structural issue of subdued revenue growth and sagging profit margins

Volumes contributed just 0.7 percentage points of the 7.6 percent growth of Indian pharmaceutical market in FY24

Annual profit margins remain below pre-pandemic years despite the recent improvement

Grounding of aircraft due to maintenance, pilot unavailability, shoddy planning are some of the aviation sector’s problems that threaten to continue and bother passengers

The company’s market share in India remained steady at around 60 percent in January-March 2024

Limited water availability has adversely impacted rabi crop season in Southern states

Exports in the eleven months to February 2024 are up 15 percent from the year ago period

The company’s key growth engines are not yet firing on all cylinders

The pre-construction capacities are estimated to have risen to 46,033 megawatts

Ordering activity revived in thermal power and transmission sectors after a prolonged period of sluggishness

While the long-term business growth strategy remains promising, the near-term environment remains quite challenging

US sales are projected to grow at a faster pace than Indian sales in Q4 FY24

PI’s business remains shielded from the sensitivities attached to the agrochemical business

While premium and discretionary categories are doing well, staples are in the doghouse. Listed companies are blaming it on unfavourable macros, but the Street is getting tired of these excuses

The impact is already visible on tractor sales. Paddy and pulses cultivation declined in 2023-24 rabi crop season

India's rise as an economic superpower will be incomplete if it does not have a thriving healthcare industry, founded on innovation and not merely focused on making generic products

Huge room to benefit from the synergies between paediatric and maternity care services

Coal power plants have fuel inventories equivalent to 17 days of consumption versus 12 days in the year ago period

Total revenues declined by 6 percent in 9M FY24 as pipes business faced market share loss